Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 4,028,640 |
|
|||||
| News | - | ||||||
| Day High | 0.765 | Low High |
|||||
| Day Low | 0.6873 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tharimmune Inc | THAR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0211 | -2.89% | 0.71 | 19:59:34 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.765 | 0.6873 | 0.765 | 0.7002 | 0.7311 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 27,151 | 4,028,640 | $ 0.7112513 | $ 2,865,375 | - | 0.6873 - 9.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:36 | 10 | $ 0.70 | USD |
Tharimmune Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.99M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Tharimmune News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical THAR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.06 | 1.08 | 0.6873 | 0.9061683 | 3,409,357 | -0.35 | -33.02% |
| 1 Month | 6.5225 | 6.75 | 0.6873 | 4.66 | 4,825,573 | -5.81 | -89.11% |
| 3 Months | 5.50 | 9.50 | 0.6873 | 5.33 | 3,053,344 | -4.79 | -87.09% |
| 6 Months | 5.50 | 9.50 | 0.6873 | 5.33 | 3,053,344 | -4.79 | -87.09% |
| 1 Year | 5.50 | 9.50 | 0.6873 | 5.33 | 3,053,344 | -4.79 | -87.09% |
| 3 Years | 5.50 | 9.50 | 0.6873 | 5.33 | 3,053,344 | -4.79 | -87.09% |
| 5 Years | 5.50 | 9.50 | 0.6873 | 5.33 | 3,053,344 | -4.79 | -87.09% |
Tharimmune Description
| Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for drug-resistant and devastating cancers. |
